Cancer Center Associate Director and Chief of Hematology/Oncology José Baselga, MD, PhD, continues our quest to bring the most promising targeted therapies from the bench to the bedside.
A look to the future of personalized medicine
José Baselga, MD, PhD
In July 2010, the Massachusetts General Hospital Cancer Center welcomed new Chief of Hematology/Oncology and Associate Director, José Baselga, MD, PhD. Dr. Baselga has since established a strong research presence at the Cancer Center focused on discovering and improving targeted therapies, with a particular emphasis on breast cancer.
Dr. Baselga’s work will build upon our efforts to integrate early-phase clinical and translational research with advanced, personalized patient care. Some highlights of his work include:
With Dr. Baselga now leading translational and early-phase clinical research, the Mass General Cancer Center is prepared to aggressively advance the search for targeted anti-cancer agents and identify new therapies for treatment-resistant cancers.
Learn more about how Dr. Baselga’s work is advancing personalized medicine:
For more about targeted therapies and innovative treatments at the Cancer Center:
U.S. News & World Report ranks Mass General the #1 hospital in America based on our quality of care, patient safety and reputation in 16 different specialties. Learn more about why we're #1.
Search the archive for previously published news articles, press releases and publications.
Departments and Centers at Mass General have a reputation for excellence in patient care. View a list of all departments.